Delivery of dehydroepiandrosterone to premenopausal women: Effects of micronization and nonoral administration

American Journal of Obstetrics and Gynecology

Volumn 174, Issue 2, 1996, Pages 649-653

  Casson, P R ^a   Straughn, A B ^a   Umstot, E S ^a   Abraham, G E ^a   Carson, S A ^a   Buster, J E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

administration; dehydroepiandrosterone; Dehydroepiandrosterone; micronization; de hydroepiandrosterone; vaginal administration

Indexed keywords

PRASTERONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TRANSFORMATION; DRUG TRANSPORT; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVAGINAL DRUG ADMINISTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE OSTEOPOROSIS; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

EID: 0030022941     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70444-1     Document Type: Article

References (15)

1. JE Nestler CO Barlascini JN Clore WG Blackard Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men J Clin Endocrinol Metab 66 1988 57 61
2. PR Casson RN Andersen HG Herrod Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women AM J OBSTET GYNECOL 169 1993 1536 1539
3. PR Casson LC Faquin FB Stentz Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women Fertil Steril 63 1995 1027 1031
4. E Barrett-Connor KT Khaw SSC Yen A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease N Engl J Med 315 1986 1519 1524
5. P Taelman JM Kaufman X Janssens A Vermeulen Persistence of increased bone resorption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late postmenopause Maturitas 11 1989 65 73
6. B Zumoff J Levin RS Rosenfeld M Markham GW Strain DK Fukushima Abnormal 24-hr mean plasma concentrations of dehydroepiandrosterone sulfate in women with primary operable breast cancer Cancer Res 41 1981 3360 3363
7. RV Haning Jr RJ Hackett CA Flood JS Loughlin Jr QY Zhao C Longcope Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins J Clin Endocrinol Metab 76 1993 1301 1307
8. LN Parker WD Odell Decline of adrenal androgen production measured by radioimmunoassay of urinary unconjugated dehydroepiandrosterone J Clin Endocrinol Metab 47 1978 600 602
9. PR Casson J Fisher ES Umstot A Milem GE Abraham JE Buster Vaginal dehydroepiandrosterone (DHEA) bioavailability in a hypopituitary woman with induction of adrenarche [Abstract P17] Proceedings of the forty-first annual meeting of the Society for Gynecologic Investigation, Chicago, Illinois, March 22-26, 1994 1994 Society for Gynecologic Investigation Chicago
10. T Yamaji H Ibayashi Plasma DHEA-S in normal and pathological conditions J Clin Endocrinol Metab 29 1969 273 278
11. G Cutler S Davis R Johnsonbaush D Loriaux Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency J Clin Endocrinol Metab 49 1979 604
12. LN Parker ER Levin ET Lifrak Evidence for adrenocortical adaptation to severe illness J Clin Endocrinol Metab 60 1985 947 952
13. JF Mortola SSC Yen The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in post-menopausal women J Clin Endocrinol Metab 71 1990 696 704
14. JE Buster PR Casson AB Straughn Postmenopausal steroid replacement with micronized dehydroepiandrosterone (DHEA): preliminary oral bioavailability and dose proportionality studies AM J OBSTET GYNECOL 166 1992 1163 1170
15. RA Wild ES Umstot RN Andersen GB Ranney JR Givens Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism AM J OBSTET GYNECOL 146 1983 602 606